Evidence map›Paper›PMID 27881076›Full record

ArticleBMC bioinformatics2016

Clustering of disulfide-rich peptides provides scaffolds for hit discovery by phage display: application to interleukin-23.

David T Barkan, Xiao-Li Cheng, Herodion Celino, Tran T Tran, Ashok Bhandari, Charles S Craik, Andrej Sali, Mark L Smythe

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Tangled Tail of Mechanically Interlocked Peptides.Journal of the American Chemical Society · 2026
    Review
  2. Application of phage surface display for the identification of EuFrontiers in bioengineering and biotechnology · 2025
    Article
  3. Review
  4. Miniproteins as a Powerful Modality in Drug Development.Trends in biochemical sciences · 2020
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

David T BarkanProtagonist Therapeutics, Inc., 521 Cottonwood Drive, Suite 100, Milpitas, CA, 95035-74521, USA.
Xiao-Li ChengProtagonist Therapeutics, Inc., 521 Cottonwood Drive, Suite 100, Milpitas, CA, 95035-74521, USA.
Herodion CelinoProtagonist Therapeutics, Inc., 521 Cottonwood Drive, Suite 100, Milpitas, CA, 95035-74521, USA.
Tran T TranProtagonist Therapeutics, Inc., 521 Cottonwood Drive, Suite 100, Milpitas, CA, 95035-74521, USA.
Ashok BhandariProtagonist Therapeutics, Inc., 521 Cottonwood Drive, Suite 100, Milpitas, CA, 95035-74521, USA.
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158, USA.
Andrej SaliDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, 94158, USA.
Mark L SmytheProtagonist Therapeutics, Inc., 521 Cottonwood Drive, Suite 100, Milpitas, CA, 95035-74521, USA. m.smythe@protagonist-inc.com.
Protagonist Therapeutics (United States) · USQB3 · USThe University of Queensland · AUUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDisulfide-rich peptides (DRPs) are found throughout nature. They are suitable scaffolds for drug development due to their small cores, whose disulfide bonds impart extraordinary chemical and biological stability. A challenge in developing a DRP therapeutic is to engineer binding to a specific target. This challenge can be overcome by (i) sampling the large sequence space of a given scaffold through a phage display library and by (ii) panning multiple libraries encoding structurally distinct scaffolds. Here, we implement a protocol for defining these diverse scaffolds, based on clustering structurally defined DRPs according to their conformational similarity.

resultsWe developed and applied a hierarchical clustering protocol based on DRP structural similarity, followed by two post-processing steps, to classify 806 unique DRP structures into 81 clusters. The 20 most populated clusters comprised 85% of all DRPs. Representative scaffolds were selected from each of these clusters; the representatives were structurally distinct from one another, but similar to other DRPs in their respective clusters. To demonstrate the utility of the clusters, phage libraries were constructed for three of the representative scaffolds and panned against interleukin-23. One library produced a peptide that bound to this target with an IC

conclusionsMost DRP clusters contained members that were diverse in sequence, host organism, and interacting proteins, indicating that cluster members were functionally diverse despite having similar structure. Only 20 peptide scaffolds accounted for most of the natural DRP structural diversity, providing suitable starting points for seeding phage display experiments. Through selection of the scaffold surface to vary in phage display, libraries can be designed that present sequence diversity in architecturally distinct, biologically relevant combinations of secondary structures. We supported this hypothesis with a proof-of-concept experiment in which three phage libraries were constructed and panned against the IL-23 target, resulting in a single-digit μM hit and suggesting that a collection of libraries based on the full set of 20 scaffolds increases the potential to identify efficiently peptide binders to a protein target in a drug discovery program.

Indexed as

Peptide LibraryAmino Acid SequenceBacteriophagesCluster AnalysisDisulfidesDrug DiscoveryHumansInterleukin-23PeptidesSequence Homology, Amino AcidDisulfidesInterleukin-23Peptide LibraryPeptidesClusteringDisulfide-rich peptidesDrug discoveryInterleukin-23KnottinsPhage displayStructure conservation

Identifiers

PMID27881076
PMCPMC5120537
OpenAlexW2549260409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.